- Letrozole2006 | Publication without faculty affiliation
- Erythrocyte Alpha-Tocopherol in Breast Cancer Patients Treated with Letrozol2010 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Research Report University Hospital for clinical assessment A5481008Publication without faculty affiliation
- Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial2012 | First Faculty of Medicine
- Aromatase inhibitors and their place in the adjuvant treatment of breast cancer2008 | First Faculty of Medicine
- Palbociclib in the treatment of metastatic breast cancer2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Erythrocyte alpha-tocopherol in breast cancer patients treated with letrozol2010 | Central Library of Charles University
- Ribociclib2018 | First Faculty of Medicine
- Does patient education work in breast cancer? Final results from the global CARIATIDE study2015 | First Faculty of Medicine
- A case report of metastatic breast cancer mimicking gastric cancer treated with palbociclib2020 | Publication without faculty affiliation
- Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome2021 | First Faculty of Medicine
- Impact of BOLERO-2 study results on clinical practice and future treatment of postmenopausal patients with advance HR+/HER2- breast cancer2014 | First Faculty of Medicine
- Palbociclib - a new dimension in palliative therapy of breast cancer2017 | First Faculty of Medicine
- Strategies for managing endocrine resistance in advanced hormone receptor-positive and HER2-negative breast cancer2017 | First Faculty of Medicine
- Current options for lapatinib in the treatment of HER2-positive breast cancer2013 | First Faculty of Medicine